SCHEMBL13348240

SCHEMBL13348240

COc1cccc(C(=O)N2CCc3cccc(COc4ccc(CCC=O)c(F)c4)c32)c1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 5/20 0.49
PTGER4 P35408 4/20 0.49
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 1/20 0.43
ALDH1A1 P00352 4/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.41
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
GRIN2C Q14957 1/20 0.39
MAPT P10636 1/20 0.38
HSD17B10 Q99714 1/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38
RAB9A P51151 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13312477 0.89 PTGER2 (0.51) PTGER2PTGER4SMN1; SMN2TSHRALDH1A1
SCHEMBL13348283 0.86 ALDH1A1 (0.46) PTGER2PTGER4ALDH1A1KMT2AMEN1
SCHEMBL13348138 0.85 HPD (0.41) PTGER2PTGER4SMN1; SMN2TSHRALDH1A1
SCHEMBL13348170 0.84 PTGER4 (0.39) PTGER2PTGER4SMN1; SMN2ALDH1A1MAPT
SCHEMBL13348407 0.84 FFAR1 (0.38) PTGER2PTGER4ALDH1A1KMT2AMEN1
SCHEMBL13312492 0.82 PTGER4 (0.53) PTGER2PTGER4SMN1; SMN2RAB9ALMNA
SCHEMBL13348045 0.81 DRD2 (0.39) PTGER2PTGER4TSHRALDH1A1KMT2A
SCHEMBL13312487 0.80 PTGER4 (0.43) PTGER2PTGER4ALDH1A1KMT2AMEN1
SCHEMBL13312462 0.80 FFAR1 (0.46) PTGER2PTGER4RAB9A
SCHEMBL13312482 0.80 FFAR1 (0.47) PTGER2PTGER4ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES ASTELLAS PHARMA INC. (JP) 2010-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152165-A1 CARBOXYLIC ACID DERIVATIVES GPR119, GPR65, HCAR1 PTGER2 3346/4885PTGER4 1432/4885SMN1; SMN2 4313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.